Sustainable Pharma Revolution: Remlife and JiyaYu's Green Partnership

Remlife Global PTE LTD., an extension of BSE-listed Remedium Lifecare Ltd., has teamed up with JiyaYu Lifesciences, marking a significant step toward sustainable pharmaceutical manufacturing. This collaboration aims to replace the use of animal-origin materials with innovative fermentation and biocatalyst alternatives.

JiyaYu will provide Remlife with cutting-edge, fully scalable technologies, which will be implemented at various GMP-compliant sites in India, Singapore, Malta, Ireland, Belgium, and Italy. This shift aligns with the industry's ethical objectives and seeks to strengthen supply chain resilience against geopolitical and regulatory disruptions.

The partnership not only promises substantial commercial potential, with projects worth ₹50 crore each, but also anticipates EBITDA margins of 20% to 25%. With this strategic collaboration, Remlife Global envisions a future centered on cruelty-free, environmentally friendly pharmaceutical solutions.

(With inputs from agencies.)